Please use this identifier to cite or link to this item:
logo share SHARE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

A GSK-3b modulator delays photoreceptor cell death and preserves visual function in the rd10 mouse model of retinitis pigmentosa

AuthorsHernández-Sánchez, Catalina CSIC ORCID ; Villarejo-Zori, Beatriz CSIC ORCID ; Zaldívar-Díez, Josefa CSIC ORCID; Marchena, Miguel CSIC ORCID; Gil, Carmen CSIC ORCID ; Villa, Pedro de la; Martínez Gil, Ana CSIC ORCID ; De la Rosa, Enrique J. CSIC ORCID
Issue DateMay-2016
PublisherAssociation for Research in Vision and Ophthalmology
CitationARVO 2016 (Seatle) "Research: A Vision for Hope" (pág.5)
AbstractRetinitis pigmentosa (RP) is a heterogeneous group of inherited retinal dystrophies that lead to blindness. Photoreceptor cell death, reactive gliosis and retinal inammation are common features in animal models of the disease. The enzyme Glycogen Synthase Kinase-3 Beta (GSK-3b) is involved in inammatory processes associated to diverse neurodegenerative pathologies. The aim of our study is to test in the rd10 mouse whether the GSK-3b inhibitor VP3.15 (a small heterocyclic molecule) is a potential therapeutic treatment for RP.
Description1 p.
Publisher version (URL)
Appears in Collections:(CIB) Comunicaciones congresos

Files in This Item:
File Description SizeFormat
E. de la Rosa_abstract-pag.5 .pdfComunicación Congreso189,91 kBAdobe PDFThumbnail
Show full item record
Review this work

CORE Recommender

Page view(s)

checked on Jul 21, 2024


checked on Jul 21, 2024

Google ScholarTM


This item is licensed under a Creative Commons License Creative Commons